|Publication number||US20080228024 A1|
|Application number||US 11/981,182|
|Publication date||Sep 18, 2008|
|Filing date||Oct 31, 2007|
|Priority date||Mar 15, 2007|
|Also published as||CA2679460A1, CN101636198A, EP2121133A1, US8740873, US20080228150, US20100048979, US20110040139, WO2008115399A1|
|Publication number||11981182, 981182, US 2008/0228024 A1, US 2008/228024 A1, US 20080228024 A1, US 20080228024A1, US 2008228024 A1, US 2008228024A1, US-A1-20080228024, US-A1-2008228024, US2008/0228024A1, US2008/228024A1, US20080228024 A1, US20080228024A1, US2008228024 A1, US2008228024A1|
|Inventors||Michael L. Jones, Frank R. Louw|
|Original Assignee||Senorx, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Referenced by (13), Classifications (8), Legal Events (2)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation-in-part of application Ser. No. 11/724,578 filed Mar. 15, 2007 which is incorporated herein in its entirety by reference and from which priority is claimed.
This invention relates generally to the fields of medical treatment devices and methods of use. In particular, the invention relates to devices and methods for irradiating tissue surrounding a body cavity, such as a site from which cancerous, pre-cancerous, or other tissue has been removed.
In diagnosing and treating certain medical conditions, it is often desirable to perform a biopsy, in which a specimen or sample of tissue is removed for pathological examination, tests and analysis. A biopsy typically results in a biopsy cavity occupying the space formerly occupied by the tissue that was removed. As is known, obtaining a tissue sample by biopsy and the subsequent examination are typically employed in the diagnosis of cancers and other malignant tumors, or to confirm that a suspected lesion or tumor is not malignant. Treatment of cancers identified by biopsy may include subsequent removal of tissue surrounding the biopsy site, leaving an enlarged cavity in the patient's body. Cancerous tissue is often treated by application of radiation, by chemotherapy, or by thermal treatment (e.g., local heating, cryogenic therapy, and other treatments to heat, cool, or freeze tissue).
Cancer treatment may be directed to a natural cavity, or to a cavity in a patient's body from which tissue has been removed, typically following removal of cancerous tissue during a biopsy or surgical procedure. For example, U.S. Pat. No. 6,923,754 to Lubock and U.S. patent application Ser. No. 10/849,410 to Lubock, the disclosures of which are all hereby incorporated by reference in their entireties, describe devices for implantation into a cavity resulting from the removal of cancerous tissue which can be used to deliver irradiation to surrounding tissue. One form of radiation treatment used to treat cancer near a body cavity remaining following removal of tissue is “brachytherapy” in which a source of radiation is placed near to the site to be treated.
Lubock above describes implantable devices for treating tissue surrounding a cavity left by surgical removal of cancerous or other tissue that includes an inflatable balloon constructed for placement in the cavity. Such devices may be used to apply one or more of radiation therapy, chemotherapy, and thermal therapy to the tissue surrounding the cavity from which the tissue was removed. The delivery lumen of the device may receive a solid or a liquid radiation source. Radiation treatment is applied to tissue adjacent the balloon of the device by placing radioactive material such as radioactive “seeds” in a delivery lumen. Such treatments may be repeated if desired.
For example, a “MammoSite® Radiation Therapy System” (MammoSite® RTS, Proxima Therapeutics, Inc., Alpharetta, Ga. 30005 USA) includes a balloon catheter with a radiation source that can be placed within a tumor resection cavity in a breast after a lumpectomy. It can deliver a prescribed dose of radiation from inside the tumor resection cavity to the tissue surrounding the original tumor. The radiation source is typically a solid radiation source; however, a liquid radiation source may also be used with a balloon catheter placed within a body cavity (e.g., Iotrex®, Proxima Therapeutics, Inc.). A radiation source such as a miniature or micro-miniature x-ray tube may also be used (e.g. U.S. Pat. No. 6,319,188). The x-ray tubes are small, flexible and are believed to be maneuverable enough to reach the desired treatment location within a patient's body. The radiation source is to be removed following each treatment session, or remains in place as long as the balloon remains within the body cavity. Inflatable treatment delivery devices and systems, such as the MammoSite® RTS and similar devices and systems (e.g., GliaSite® RTS (Proxima Therapeutics, Inc.)), are useful to treat cancer in tissue adjacent a body cavity.
Tissue cavities resulting from biopsy or other surgical procedures such as lumpectomy typically are not always uniform or regular in their sizes and shapes, so that radiation treatment often result in differences in dosages applied to different regions of surrounding tissue, including “hot spots” and regions of relatively low dosage. However, by conforming the tissue lining the cavity about an inflated member, such as a balloon, a more uniform or controlled radiation can be applied to the tissue.
The radiation balloon catheter is usually retained within the patient for about 5-10 days during which time radiation is emitted from a radiation source within the balloon. The proximal end of the catheter is preferably folded or coiled and secured onto or under the patient's skin during the retention period. However, in order to facilitate folding or coiling the catheter shaft, the shaft must be fairly flexible or it will be difficult to maintain in the folded or coiled configuration without subjecting the patient to discomfort. The catheter shaft is formed of low durometer polymeric material in order to improve flexibility but low durometer polymeric materials have high friction surfaces, making advancing a radiation source through a lumen of the catheter shaft difficult. Forming a soft polymeric material about a single tube with a lumen with greater lubricity is not difficult but forming a soft polymeric material with a plurality of lumens with greater lubricity is problematic.
This invention is generally directed to irradiating tissue surrounding a patient's body cavity, and particularly to devices and methods for such treatments. The invention is particularly suitable for treating tissue adjacent a patient's body site such as a cavity formed by removal of tissue for a biopsy or lumpectomy.
More specifically, an elongated catheter device embodying features of the invention includes a flexible elongated shaft, a treatment location at a distal portion of the device, at least one lumen extending within the shaft to the treatment location which is configured to receive or which includes a radiation source. Preferably, the catheter has an inflatable cavity filling member or balloon surrounding the treatment location on the distal portion of the catheter. In this embodiment, the flexible elongated shaft is formed of relatively low durometer polymeric material, e.g. 70A to about 25D Shore Hardness, to provide flexibility. At least one, and preferably a plurality of the inner lumens are provided with a lining of relatively high durometer polymeric material, e.g. 40D to 80D Shore Hardness. The relatively low durometer polymeric material for the elongated shaft is preferably a thermoplastic elastomer such as polyurethane, e.g. Pellethane™ which is available from Dow Chemical. Other suitable polymeric material for lining the lumens include polyvinyl chloride, Styrene, ABS and other solvent dissolvable polymers. The polymeric material of the elongated shaft may be a blend or copolymer. Preferably, finely divided particulate is incorporated into the lining to decrease contact. The particulate provides an undulating or uneven surface which reduces contact with the brachytherapy seed and the friction between the seed and the coating. Generally, the particulate size is less than 0.002 inch in diameter, preferably about 0.00025 to about 0.0005 inch in diameter. The particulate preferably is insoluble in the solution and generally forms a slurry therewith. The slurry contains about 2 to about 15%, preferably about 6 to about 12% (by wt) particulate. A suitable particulate is starch particulate (S-4180) from Sigma-Aldrich, located in St. Louis, Mo.
The lining of higher durometer polymeric material is preferably applied by dissolving the higher durometer polymeric material in a suitable non-aqueous solvent, e.g. tetrahydrofuran, applying the solution to the surface of the inner lumen and then evaporating the solvent to leave the higher durometer material on the surface of the lumen. Other solvents include cyclohexanone, dimethyl formamide and mixtures thereof. Other suitable combinations of high durometer polymers and non-aqueous solvents which dissolve such polymers may be employed.
A radiation catheter device embodying features of the invention preferably has one or more inner lumens configured to be in fluid communication with a proximal vacuum source and one or more vacuum ports preferably proximal and/or distal to the cavity filling member such as described in U.S. Pat. No. 6,923,754 and co-pending application Ser. No. 10/849,410, filed on May 19, 2004, both of which are assigned to the present assignee. Application of a vacuum within the inner lumen aspirates fluid in the cavity through the one or more vacuum ports and the application of a vacuum within the body cavity pulls tissue defining the cavity onto the exterior of the inflated cavity filling member deployed within the cavity so as to conform the tissue lining to the shape of the cavity filling member.
Methods previously described in co-pending application Ser. No. 11/357,274, filed on Feb. 17, 2006 and Ser. No. 11/593,789, filed on Nov. 6, 2006 for using radiation catheters are suitable for a radiation catheter embodying features of the invention body cavity.
The present invention provides a radiation catheter having a flexible shaft to facilitate securing the shaft to or under the patient's skin in a coiled or folded configuration and a low friction lumen for advancement of a radiation source to the treatment location of the shaft. The catheter is particularly suitable for treating a cavity created by breast biopsy or lumpectomy. These and other advantages of the present invention are described in more detail in the following detailed description and the accompanying exemplary drawings.
The support element 41 has four compartments 42-45 which are designed to receive tubular radiation delivery members 35, 36, 38 and 39 respectively. The radiation delivery tubes will not usually be radially extended to the extent that they contact the interior surface of the balloon 12 in an inflated condition.
The expansion of the balloon 12 is illustrated in
About 1.4 grams of a high durometer polyester polyurethane polymer (Pellethane™) having a durometer hardness of 65D Shore was dissolved in 90 ml of tetrahydrofuran which is a non-aqueous solvent. A flexible catheter shaft having a plurality of lumens and formed of relatively low durometer polyurethane was positioned vertically with the lower lumen openings closed off by a plug as shown in
About 1.2 grams of a high durometer polyester polyurethane polymer (Pellethane™) having a durometer hardness of 55D Shore was dissolved in 80 ml of tetrahydrofuran which is a non-aqueous solvent. Eight grams of finely divided starch was mixed into the solution to form a slurry. A lumen of a flexible catheter shaft formed of relatively low durometer polyurethane was lined with the slurry of tetrahydorfuran, polyurethane polymer and particulate starch and allowed dry, evaporating the solvent and leaving the high durometer polyurethane solute and particulate tenaciously lining the lumens. The lumens lined with the high durometer polyurethane and starch particulate. Brachytherapy seeds could be readily advanced through the lined lumens, whereas advancement through the lumens before the application of the lining was difficult.
If desired, a colorant such as an ink, dye or pigment may be added to the polymeric coating to aid in identifying one or more lumens. Friction reducing compounds such a zinc stearate (a mold release agent), surfactants such a polyvinyl alcohol or lubricants such as Carnauba wax may also be added to the coating. Except for pigments, such additives should be at least partially soluble in the solvent.
Pigments such as Reactive Blue, Prussian Blue, iron oxide, titanium dioxide, manganese violet, ultramarine blue and others may be suspended in the polymer solution in particulate form to be deposited with the polymeric material. The pigment particles provide an undulating or uneven surface which reduces contact with the brachytherapy seed and the friction between the seed and the coating as previously described.
In one series of tests a lumen in a catheter shaft formed of a polyurethane having an 80A Shore Hardness was lined with a polyurethane having a 55D Shore Hardness as described above. The lined lumen exhibited a reduction of 75% of the force required to advance a brachytherapy seed through the lumen over an uncoated lumen of the same material. Incorporating Reactive Blue pigment into the polyurethane coating reduced the force required to advance the Brachytherapy seed through the lumen by almost 90% of the force required to advance the seed through an uncoated lumen of the same material.
All of the radiation delivery tubes which extend through the interior of the balloon 12 would not necessarily be used in a particular irradiation procedure, but they would be available for use by the physician if needed, e.g. when the balloon 12 of the radiation catheter 10 is not in a desired position and rotation of the catheter is not appropriate or desirable.
The radiation source 26 for the brachytherapy device 10 is shown as a radiation seed on the distal end of rod 41. The radiation source 26 preferably includes brachytherapy seeds or other solid radiation sources used in radiation therapy. A micro-miniature x-ray catheter may also be utilized. The radiation source 26 may be either preloaded into the device 10 at the time of manufacture or may be loaded into the device 10 just before or after placement into a body cavity or other site of a patient. Solid radionuclides suitable for use with a device 10 embodying features of the present invention are currently generally available as brachytherapy radiation sources (e.g., I-Plant. TM. Med-Tec, Orange City, Iowa.). Radiation may also be delivered by a micro-miniature x-ray catheter device such as described in U.S. Pat. No. 6,319,188. The x-ray catheter devices are small, flexible and are believed to be maneuverable enough to reach the desired location within a patient's body.
The radiation source 26 preferably is one or more brachytherapy seeds, for example, a radioactive microsphere available from 3M Company of St. Paul, Minn. Other suitable brachytherapy radiation sources include I-Plant™, (Med-Tec, Orange City, Iowa.).
The device 10 can be provided, at least in part, with a lubricious exterior coating, such as a hydrophilic material. The lubricious coating preferably is applied to the elongate shaft 11 or to the balloon 12 or both, to reduce sticking and friction during insertion and withdrawal of the device 10. Hydrophilic coatings such as those provided by AST, Surmodics, TUA Systems, Hydromer, or STS Biopolymers are suitable. The surfaces of the device 10 may also include an antimicrobial coating that covers all or a portion of the device 10 to minimize the risk of introducing of an infection during extended treatments. The antimicrobial coating preferably is comprised of silver ions impregnated into a hydrophilic carrier. Alternatively the silver ions are implanted onto the surface of the device 10 by ion beam deposition. The antimicrobial coating may also be an antiseptic or disinfectant such as chlorhexadiene, benzyl chloride or other suitable biocompatible antimicrobial materials impregnated into hydrophilic coatings. Antimicrobial coatings such as those provided by Spire, AST, Algon, Surfacine, Ion Fusion, or Bacterin International would be suitable. Alternatively a cuff member covered with the antimicrobial coating may be provided on the elongated shaft of the delivery device 10 at the point where the device 10 enters the patient's skin.
The device 10 may be used to treat a body cavity of a patient in the manner described in the previously referred to co-pending applications. Usually the adapter 15 on the proximal end of the catheter device extends out of the patient during the procedure when the balloon is inflated. The catheter shaft 11 is preferably flexible enough along a length thereof, so that once the balloon is inflated to a turgid condition, the catheter shaft can be folded or coiled and secured to or placed under the patient's skin before the exterior opening of the treatment passageway to the treatment site is closed. At the end of the treatment time, e.g. 5-10 days, the exterior opening can be reopened and the catheter removed from the patient. See for example the discussion thereof in previously discussed co-pending application Ser. No. 11/357,274. The coiled or folded flexible shaft does not cause significant discomfort to the patient while secured to or under the patient's skin.
Typically, radiation balloon catheters for breast implantation are about 6 to about 12 inches in length. The catheter shaft is about 0.25 to about 0.4 inch (6.4-10.2 mm) transverse dimensions. The size of individual radiation lumens depends upon the size of the radiation source, but generally are about 0.02 to about 0.2 inch (0.5-5.1 mm), preferably about 0.04 to about 0.1 inch (1-2.5 mm). The inflation and vacuum lumens in the shaft are about 0.03 to about 0.0.08 inch (0.8-2 mm). The balloons are designed for inflated configurations about 0.5 to about 4 inches, typically about 1 to about 3 inches in transverse dimensions, e.g. diameters.
While particular forms of the invention have been illustrated and described herein, it will be apparent that various modifications and improvements can be made to the invention. To the extend not described herein, the various elements of the catheter device may be made from conventional materials used in similar devices and the design and size of various components may follow similar devices know in the art. Moreover, individual features of embodiments of the invention may be shown in some drawings and not in others, but those skilled in the art will recognize that individual features of one embodiment of the invention can be combined with any or all the features of another embodiment. Accordingly, it is not intended that the invention be limited to the specific embodiments illustrated. It is therefore intended that this invention be defined by the scope of the appended claims as broadly as the prior art will permit.
Terms such as “element”, “member”, “component”, “device”, “means”, “manufacture”, “portion”, “section”, “steps” and words of similar import when used herein shall not be construed as invoking the provisions of 35 U.S.C. §112(6) unless the following claims expressly use the terms “means for” or “step for” followed by a particular function without reference to a specific structure or action. All patents and all patent applications referred to above are hereby incorporated by reference in their entirety.
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8057379||Jan 31, 2008||Nov 15, 2011||Senorx, Inc.||Treatment of a body cavity|
|US8075469||Dec 13, 2011||Senorx, Inc.||Methods for asymmetrical irradiation of a body cavity|
|US8251884||May 2, 2008||Aug 28, 2012||Senorx, Inc.||Methods for asymmetrical irradiation of a body cavity|
|US8273006||Apr 14, 2009||Sep 25, 2012||Senorx, Inc.||Tissue irradiation|
|US8277370||Oct 30, 2007||Oct 2, 2012||Senorx, Inc.||Radiation catheter with multilayered balloon|
|US8287442||Mar 12, 2007||Oct 16, 2012||Senorx, Inc.||Radiation catheter with multilayered balloon|
|US8292794||Apr 27, 2011||Oct 23, 2012||Senorx, Inc.||Method for maintaining access to a biopsy site|
|US8328710||Feb 17, 2006||Dec 11, 2012||Senorx, Inc.||Temporary catheter for biopsy site tissue fixation|
|US8398535||Mar 22, 2011||Mar 19, 2013||Senorx, Inc.||Catheter assembly for delivering a radiation source into a body cavity|
|US8517906||Apr 8, 2011||Aug 27, 2013||Hologic, Inc.||Brachytherapy device|
|US8636637||Aug 10, 2012||Jan 28, 2014||Hologic, Inc||Methods for asymmetrical irradiation of a body cavity|
|US8740763||Jan 25, 2013||Jun 3, 2014||Hologic Inc.||Multilumen brachytherapy balloon catheter|
|US8758214||Oct 11, 2012||Jun 24, 2014||Hologic, Inc.||Radiation catheter with multilayered balloon|
|International Classification||A61F2/958, A61M36/04|
|Cooperative Classification||A61L29/085, A61N5/1015, A61M2025/0047|
|European Classification||A61L29/08B, A61N5/10B4E|
|Feb 5, 2008||AS||Assignment|
Owner name: SENORX, INC, CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JONES, MICHAEL L.;LOUW, FRANK R.;REEL/FRAME:020453/0675;SIGNING DATES FROM 20080111 TO 20080117
|Jun 3, 2013||AS||Assignment|
Owner name: HOLOGIC, INC., MASSACHUSETTS
Effective date: 20130531
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SENORX, INC.;REEL/FRAME:030530/0229